Repligen
RGEN
#1861
Rank
NZ$19.28 B
Marketcap
NZ$301.76
Share price
-2.62%
Change (1 day)
9.25%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): NZ$52.73 Million

According to Repligen 's latest financial reports the company's current earnings are NZ$0.80 Billion. In 2025 the company made an earning of NZ$0.15 Billion, an increase over its 2024 earnings that were of -NZ$11.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$52.73 M-65.46%
2025 NZ$0.15 B-1430.84%
2024 -NZ$11.48 Million-113.01%
2023 NZ$88.16 M-78.01%
2022 NZ$0.40 B33.37%
2021 NZ$0.30 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$64.49 M25.93%
2018 NZ$51.22 M105.61%
2017 NZ$24.91 M-11.46%
2016 NZ$28.13 M14.91%
2015 NZ$24.48 M20.26%
2014 NZ$20.36 M-51.49%
2013 NZ$41.97 M90.98%
2012 NZ$21.97 M
2010 NZ$0.31 M-103.81%
2009 -NZ$8.35 Million-223.84%
2008 NZ$6.74 M
2006 -NZ$4.53 Million229.64%
2005 -NZ$1.38 Million-89.16%
2004 -NZ$12.68 Million-16.86%
2003 -NZ$15.25 Million88.72%
2002 -NZ$8.08 Million-27.88%
2001 -NZ$11.21 Million-1.74%
2000 -NZ$11.4 Million85.93%
1999 -NZ$6.14 Million159.16%
1998 -NZ$2.37 Million85.71%
1997 -NZ$1.28 Million-70.83%
1996 -NZ$4.37 Million-72.41%
1995 -NZ$15.84 Million-60.63%
1994 -NZ$40.22 Million45.39%
1993 -NZ$27.67 Million39.45%
1992 -NZ$19.84 Million-32.3%
1991 -NZ$29.3 Million6.62%
1990 -NZ$27.48 Million1577.78%
1989 -NZ$1.64 Million-57.14%
1988 -NZ$3.83 Million-362.5%
1987 NZ$1.45 M-130.77%
1986 -NZ$4.74 Million136.36%
1985 -NZ$2.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.68 B 22,613.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$14.37 B 25,648.09%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$21.37 B 38,188.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.62 B 36,838.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.21 Billion-459.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.41 Billion-828.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.57 B 2,713.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.45 B 715.93%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$79.46 M 42.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-NZ$0.19 Billion-426.66%๐Ÿ‡บ๐Ÿ‡ธ USA